全文获取类型
收费全文 | 45715篇 |
免费 | 5151篇 |
国内免费 | 242篇 |
专业分类
耳鼻咽喉 | 921篇 |
儿科学 | 1354篇 |
妇产科学 | 984篇 |
基础医学 | 4244篇 |
口腔科学 | 902篇 |
临床医学 | 6455篇 |
内科学 | 9461篇 |
皮肤病学 | 942篇 |
神经病学 | 2999篇 |
特种医学 | 1886篇 |
外国民族医学 | 1篇 |
外科学 | 7915篇 |
综合类 | 855篇 |
现状与发展 | 2篇 |
一般理论 | 28篇 |
预防医学 | 4065篇 |
眼科学 | 1729篇 |
药学 | 2876篇 |
1篇 | |
中国医学 | 146篇 |
肿瘤学 | 3342篇 |
出版年
2024年 | 105篇 |
2023年 | 693篇 |
2022年 | 651篇 |
2021年 | 1522篇 |
2020年 | 1087篇 |
2019年 | 1191篇 |
2018年 | 1806篇 |
2017年 | 1437篇 |
2016年 | 1469篇 |
2015年 | 1694篇 |
2014年 | 2134篇 |
2013年 | 2818篇 |
2012年 | 3025篇 |
2011年 | 3001篇 |
2010年 | 1909篇 |
2009年 | 1900篇 |
2008年 | 2444篇 |
2007年 | 2305篇 |
2006年 | 2288篇 |
2005年 | 2031篇 |
2004年 | 1854篇 |
2003年 | 1626篇 |
2002年 | 1473篇 |
2001年 | 892篇 |
2000年 | 752篇 |
1999年 | 785篇 |
1998年 | 573篇 |
1997年 | 550篇 |
1996年 | 545篇 |
1995年 | 492篇 |
1994年 | 391篇 |
1993年 | 298篇 |
1992年 | 435篇 |
1991年 | 431篇 |
1990年 | 392篇 |
1989年 | 366篇 |
1988年 | 339篇 |
1987年 | 344篇 |
1986年 | 296篇 |
1985年 | 305篇 |
1984年 | 248篇 |
1983年 | 240篇 |
1982年 | 203篇 |
1981年 | 218篇 |
1980年 | 161篇 |
1979年 | 190篇 |
1978年 | 137篇 |
1977年 | 116篇 |
1976年 | 97篇 |
1973年 | 112篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
Suzannah M. Schmidt-Malan Melissa J. Karau Julia Cede Kerryl E. Greenwood-Quaintance Cassandra L. Brinkman Jayawant N. Mandrekar Robin Patel 《Antimicrobial agents and chemotherapy》2015,59(8):4610-4615
Bacterial biofilms are difficult to treat using available antimicrobial agents, so new antibiofilm strategies are needed. We previously showed that 20, 200, and 2,000 μA of electrical current reduced bacterial biofilms of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. Here, we tested continuous direct current at lower amperages, intermittent direct current, and combinations of surface materials (Teflon or titanium) and electrode compositions (stainless steel, graphite, titanium, or platinum) against S. aureus, S. epidermidis, and P. aeruginosa biofilms. In addition, we tested 200 or 2,000 μA for 1 and 4 days against biofilms of 33 strains representing 13 species of microorganisms. The logarithmic reduction factor was used to measure treatment effects. Using continuous current delivery, the lowest active amperage was 2 μA for 1, 4, or 7 days against P. aeruginosa and 5 μA for 7 days against S. epidermidis and S. aureus biofilms. Delivery of 200 μA for 4 h a day over 4 days reduced P. aeruginosa, S. aureus, and S. epidermidis biofilms on Teflon or titanium discs. A reduction of P. aeruginosa, S. aureus, and S. epidermidis biofilms was measured for 23 of 24 combinations of surface materials and electrode compositions tested. Four days of direct current delivery reduced biofilms of 25 of 33 strains studied. In conclusion, low-amperage current or 4 h a day of intermittent current delivered using a variety of electrode compositions reduced P. aeruginosa, S. aureus, and S. epidermidis biofilms on a variety of surface materials. The electricidal effect was observed against a majority of bacterial species studied. 相似文献
982.
Examination criteria and calibration procedures for prevention trials of the Early Childhood Caries Collaborating Centers 下载免费PDF全文
983.
984.
Hepatitis C virus (HCV) is a leading cause of chronic liver disease, and efforts to develop therapeutic vaccine strategies have been limited by immune escape due to HCV variants that are resistant to current vaccines or HCV variants that rapidly acquire new resistance-conferring mutations. Recently, the crystal structure of the viral envelope protein E2 region was resolved as well as how E2 docks to the host CD81 protein; therefore, antibodies that block this interaction should prevent viral entry into host cells. In this issue of the JCI, Bailey and colleagues show that immune escape of HCV can occur by naturally occurring polymorphisms in E2 that are distinct from those at mapped sites of antibody binding. These data reveal alternative mechanisms of resistance that need to be considered in both natural viral escape as well as in rationale vaccine design against HCV. 相似文献
985.
Meha P. Patel Bartlomiej G. Fryszczyn Timothy Palzkill 《Antimicrobial agents and chemotherapy》2015,59(11):6741-6748
The widespread use of oxyimino-cephalosporin antibiotics drives the evolution of the CTX-M family of β-lactamases that hydrolyze these drugs and confer antibiotic resistance. Clinically isolated CTX-M enzymes carrying the P167S or D240G active site-associated adaptive mutation have a broadened substrate profile that includes the oxyimino-cephalosporin antibiotic ceftazidime. The D240G substitution is known to reduce the stability of CTX-M-14 β-lactamase, and the P167S substitution is shown here to also destabilize the enzyme. Proteins are marginally stable entities, and second-site mutations that stabilize the enzyme can offset a loss in stability caused by mutations that enhance enzyme activity. Therefore, the evolution of antibiotic resistance enzymes can be dependent on the acquisition of stabilizing mutations. The A77V substitution is present in CTX-M extended-spectrum β-lactamases (ESBLs) from a number of clinical isolates, suggesting that it may be important in the evolution of antibiotic resistance in this family of β-lactamases. In this study, the effects of the A77V substitution in the CTX-M-14 model enzyme were characterized with regard to the kinetic parameters for antibiotic hydrolysis as well as enzyme expression levels in vivo and protein stability in vitro. The A77V substitution has little effect on the kinetics of oxyimino-cephalosporin hydrolysis, but it stabilizes the CTX-M enzyme and compensates for the loss of stability resulting from the P167S and D240G mutations. The acquisition of global stabilizing mutations, such as A77V, is an important feature in β-lactamase evolution and a common mechanism in protein evolution. 相似文献
986.
Evaluation of a Standardized Program for Training Practicing Anesthesiologists in Ultrasound‐Guided Regional Anesthesia Skills 下载免费PDF全文
987.
Abnormal Umbilical Artery Doppler Findings in the Recipient Twin Before Laser Surgery for Twin‐Twin Transfusion Syndrome 下载免费PDF全文
988.
989.
990.
Arunaloke Chakrabarti Prashant Sood Shivaprakash M. Rudramurthy Sharon Chen Harsimran Kaur Malini Capoor Deepinder Chhina Ratna Rao Vandana Kalwaje Eshwara Immaculata Xess Anupama J. Kindo P. Umabala Jayanthi Savio Atul Patel Ujjwayini Ray Sangeetha Mohan Ranganathan Iyer Jagdish Chander Anita Arora Raman Sardana Indranil Roy B. Appalaraju Ajanta Sharma Anjali Shetty Neelam Khanna Rungmei Marak Sanjay Biswas Shukla Das B. N. Harish Sangeeta Joshi Deepak Mendiratta 《Intensive care medicine》2015,41(2):285-295